Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
284 studies found for:    Open Studies | "Parasitic Diseases"
Show Display Options
Rank Status Study
21 Unknown  Corticosteroids to Reduce Frequency of Seizures in Neurocysticercosis Patients
Condition: Neurocysticercosis
Interventions: Drug: Albendazole;   Drug: Dexamethasone;   Drug: Omeprazole
22 Recruiting Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
Condition: Toxoplasmosis
Interventions: Drug: Leucovorin calcium;   Drug: Pyrimethamine;   Drug: Spiramycin;   Drug: Sulfadiazine
23 Recruiting Treatment of Patients With Cysticercosis With Praziquantel or Albendazole
Condition: Cysticercosis
Intervention:
24 Recruiting Cardio‑Safety of Dihydroartemisinin‑Piperaquine and Pharmacokinetics of Piperaquine Amongst Pregnant Women in Tanzania
Conditions: Malaria;   Pregnancy;   Cardiotoxicity;   Parasitemia
Interventions: Drug: sulfadoxine-pyrimethamine (SP);   Drug: dihydroartemisinin-piperaquine (DHA-PQP)
25 Not yet recruiting Sertraline in Addition to Standard of Care Treatment for Coccidioidomycosis
Condition: Coccidioidomycosis
Intervention: Drug: Sertraline
26 Recruiting A Safety and Efficacy Study of R21 +/- ChAd63/MVA ME-TRAP
Condition: Malaria
Interventions: Biological: 10 µg R21/ 50 µg Matrix M1;   Biological: 50 µg R21/ 50 µg Matrix M1;   Biological: 10 µg R21/ 50 µg Matrix M1 with ChAd63-MVA ME-TRAP and MVA ME-TRAP
27 Not yet recruiting Use of Malaria Rapid Diagnostic Tests as a Decision Aid for the Management of Fever by International Travelers
Conditions: Fever;   Malaria
Intervention: Device: rapid diagnostic test for malaria antigen
28 Not yet recruiting Metabolism and Pharmacokinetics of Primaquine Enantiomers in Human Volunteers, Study 1
Condition: Malaria
Intervention: Drug: Primaquine, R-Primaquine, S-Primaquine, SR Primaquine
29 Not yet recruiting Prevalence Survey of Plasmodium Falciparum Antimalarial Drug Resistance Markers
Condition: Plasmodium Falciparum
Intervention:
30 Not yet recruiting A Study of a New Leishmania Vaccine Candidate ChAd63-KH
Condition: Leishmaniasis, Cutaneous
Intervention: Drug: ChAd63-KH
31 Not yet recruiting MMV390048 POC in Patients With P. Vivax and P. Falciparum Malaria
Condition: Malaria
Intervention: Drug: MMV390048
32 Recruiting Effect of Schistosomiasis Mansoni on HIV Susceptibility and Female Genital Immunology
Conditions: Schistosomiasis Mansoni;   HIV
Intervention: Drug: Praziquantel
33 Not yet recruiting RHOST-cRCT, Reactive Household-based Self-administered Treatment Against Residual Malaria Transmission
Condition: Malaria
Intervention: Biological: dihydroartemisinin-piperaquine
34 Not yet recruiting G6PD Assessment Before Primaquine for Radical Treatment of Vivax Malaria
Condition: Vivax Malaria
Interventions: Drug: Chloroquine;   Drug: Primaquine 0.25 mg/kg/day;   Drug: Primaquine 0.75 mg/kg weekly
35 Not yet recruiting Repeated Doses of Praziquantel in Schistosomiasis Treatment (RePST)
Condition: Schistosomiasis
Interventions: Drug: 5x Praziquantel;   Drug: 1x Praziquantel
36 Recruiting SJ733 Induced Blood Stage Malaria Challenge Study
Condition: Plasmodium Falciparum Malaria
Intervention: Drug: (+)-SJ000557733
37 Not yet recruiting Determination of Genetic Susceptibility in Severe Recurrences of Ocular Toxoplasmosis
Conditions: Toxoplasmosis Infection;   Genotype II;   Ocular Toxoplasmosis With Recurrences
Intervention: Biological: seropositive for Toxoplasma gondii
38 Not yet recruiting Safety, Tolerability and Immunogenicity of PfSPZ Vaccine in an Age De-escalation Trial in Equatorial Guinea.
Condition: Malaria
Interventions: Biological: PfSPZ Vaccine;   Biological: PfSPZ Challenge (for CHMI);   Other: Normal Saline;   Biological: PfSPZ Challenge (for PfSPZ-CVac)
39 Not yet recruiting Methylene Blue Against Falciparum Malaria in Burkina Faso
Condition: Malaria, Falciparum
Interventions: Drug: Methylene Blue;   Drug: Primaquine
40 Recruiting Pharmacokinetics & Pharmacodynamics of Diethylcarbamazine (DEC)+ Albendazole (ALB) + Ivermectin (IVE)
Condition: Wuchereria Bancrofti Infection
Intervention: Drug: Ivermectin, Diethylcarbamazine Albendazole (IDA)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years